Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2386 AL 2400

Filling the void for new Alzheimer's disease therapy

Nat Aging. 2021 Jul;1(7):567-568. doi: 10.1038/s43587-021-00092-w.

Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations

Kondo T, Banno H, Okunomiya T, Amino Y, Endo K, Nakakura A, Uozumi R, Kinoshita A, Tada H, Morita S, Ishikawa H, Shindo A, Yasuda K, Taruno Y, Maki T, Suehiro T, Mori K, Ikeda M, Fujita K, Izumi Y, Kanemaru K, Ishii K, Shigenobu K, Kutoku Y, Sunada Y, Kawakatsu S, Shiota S, Watanabe T, Uchikawa O, Takahashi R, Tomimoto H, Inoue H.

BMJ Open. 2021 Jun 30;11(6):e051343. doi: 10.1136/bmjopen-2021-051343.

Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer's Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression

Tolar M, Hey J, Power A, Abushakra S.

Int J Mol Sci. 2021 Jun 14;22(12):6355. doi: 10.3390/ijms22126355.

Vitamin K2 Holds Promise for Alzheimer's Prevention and Treatment

Popescu A, German M.

Nutrients. 2021 Jun 27;13(7):2206. doi: 10.3390/nu13072206.

Peptides Derived from Growth Factors to Treat Alzheimer's Disease

Gascon S, Jann J, Langlois-Blais C, Plourde M, Lavoie C, Faucheux N.

Int J Mol Sci. 2021 Jun 4;22(11):6071. doi: 10.3390/ijms22116071.

Exploitation of Marine Molecules to Manage Alzheimer's Disease

Silva M, Seijas P, Otero P.

Mar Drugs. 2021 Jun 28;19(7):373. doi: 10.3390/md19070373.

Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors

Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G, Andronie-Cioara FL, Toma MM, Bungau S, Bumbu AG.

Molecules. 2021 Jun 18;26(12):3724. doi: 10.3390/molecules26123724.

Metal-Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin

Prasad S, DuBourdieu D, Srivastava A, Kumar P, Lall R.

Int J Mol Sci. 2021 Jun 30;22(13):7094. doi: 10.3390/ijms22137094.

Nutraceutical and Probiotic Approaches to Examine Molecular Interactions of the Amyloid Precursor Protein APP in Drosophila Models of Alzheimer's Disease

Jalali D, Guevarra JA, Martinez L, Hung L, Vonhoff FJ.

Int J Mol Sci. 2021 Jun 29;22(13):7022. doi: 10.3390/ijms22137022.

Sleep, neuronal hyperexcitability, inflammation and neurodegeneration: Does early chronic short sleep trigger and is it the key to overcoming Alzheimer's disease?

Ahnaou A, Drinkenburg WHIM.

Neurosci Biobehav Rev. 2021 Oct;129:157-179. doi: 10.1016/j.neubiorev.2021.06.039. Epub 2021 Jun 29.

Aducanumab for Alzheimer's disease?

Walsh S, Merrick R, Milne R, Brayne C.

BMJ. 2021 Jul 5;374:n1682. doi: 10.1136/bmj.n1682.

Clinical Efficacy, Drug Safety, and Surrogate Endpoints: Has Aducanumab Met All of Its Expectations?

Hershey LA, Tarawneh R.

Neurology. 2021 Sep 14;97(11):517-518. doi: 10.1212/WNL.0000000000012453. Epub 2021 Jul 7.

Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels

Cunha S, Forbes B, Sousa Lobo JM, Silva AC.

Int J Nanomedicine. 2021 Jun 29;16:4373-4390. doi: 10.2147/IJN.S305851. eCollection 2021.

A contentious FDA ruling for Alzheimer's disease

The Lancet Neurology.

Lancet Neurol. 2021 Aug;20(8):585. doi: 10.1016/S1474-4422(21)00215-5. Epub 2021 Jul 5.

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease

Zhang H, Wei W, Zhao M, Ma L, Jiang X, Pei H, Cao Y, Li H.

Int J Biol Sci. 2021 May 27;17(9):2181-2192. doi: 10.7150/ijbs.57078. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias